i-SENS, Inc. (KOSDAQ:099190)
19,670
-320 (-1.60%)
Sep 19, 2025, 9:39 AM KST
i-SENS Market Cap
i-SENS has a market cap or net worth of 551.44 billion as of September 18, 2025. Its market cap has increased by 15.68% in one year.
Market Cap
551.44B
Enterprise Value
645.58B
Revenue
305.89B
Ranking
n/a
PE Ratio
284.83
Stock Price
19,670.00
Market Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 551.44B, an increase of 136.91%. That is a compound annual growth rate of 7.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 512.27B | 21.38% |
Dec 30, 2024 | 422.03B | -46.36% |
Dec 28, 2023 | 786.74B | 74.15% |
Dec 29, 2022 | 451.77B | 9.85% |
Dec 30, 2021 | 411.25B | 0.83% |
Dec 30, 2020 | 407.85B | 16.73% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.74T |
Celltrion | 37.16T |
ALTEOGEN | 26.35T |
Yuhan | 8,924.87B |
SK Biopharmaceuticals | 8,669.28B |
Peptron | 6,977.56B |
PharmaResearch | 6,524.70B |
ABL Bio | 5,528.46B |